NGM BIOPHARMACEUTICALS INC

CUSIP: 62921N105 Class: Common Stock

ROYAL BANK OF CANADA's Holding History (CIK: 0001000275)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 1,095 Value ($000) $2 Avg Close Range
Q4 2023
Shares 12,824 Value ($000) $11 Avg Close Range
Q3 2023
Shares 9,191 Value ($000) $10 Avg Close Range
Q2 2023
Shares 4,547 Value ($000) $12 Avg Close Range
Q1 2023
Shares 3,490 Value ($000) $14 Avg Close Range
Q4 2022
Shares 5,542 Value ($000) $28 Avg Close Range
Q3 2022
Shares 3,195 Value ($000) $41 Avg Close Range
Q2 2022
Shares 705 Value ($000) $9 Avg Close Range
Q1 2022
Shares 2,314 Value ($000) $36 Avg Close Range
Q4 2021
Shares 5,687 Value ($000) $100 Avg Close Range
Q3 2021
Shares 2,895 Value ($000) $60 Avg Close Range
Q2 2021
Shares 2,157 Value ($000) $43 Avg Close Range
Q1 2021
Shares 1,650 Value ($000) $48 Avg Close Range
Q1 2020
Shares 933,959 Value ($000) $11,516 Avg Close Range
Q4 2019
Shares 935,675 Value ($000) $17,301 Avg Close Range
Q3 2019
Shares 1,208,367 Value ($000) $16,735 Avg Close Range
Q2 2019
Shares 1,208,433 Value ($000) $17,691 Avg Close Range